comparemela.com

Latest Breaking News On - Kawasaki medical school in okayama - Page 1 : comparemela.com

RAASi Rechallenge Uncommon After Hyperkalemia, Tied With Adverse Outcomes

Investigators assessed the extent of RAASi discontinuation after a hyperkalemia episode in cardiorenal patients and its effect on hospital length of stay.

Suboptimal RAASi Therapy After Hyperkalemia Ups Cardiorenal Risks

Hyperkalemia frequently results in suboptimal use of renin-angiotensin-aldosterone system inhibitor (RAASi) therapy and cardiorenal risks.

Suboptimal RAASi Therapy After Hyperkalemia Ups Cardiorenal Risks

Hyperkalemia frequently results in suboptimal use of renin-angiotensin-aldosterone system inhibitor (RAASi) therapy and cardiorenal risks.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.